FATE LAWSUIT: Hagens Berman, National Trial Attorneys, Encourages Fate Therapeutics, Inc. (FATE) Investors with Significant Losses to Contact Firm's Attorneys, Securities Fraud Class Action FiledNewsfile Corp • 01/24/23
Shareholder Alert: Robbins LLP Informs Investors of Class Action Against Fate Therapeutics, Inc. (FATE)Business Wire • 01/24/23
FATE ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Fate Therapeutics, Inc. and Encourages Investors to Contact the FirmBusiness Wire • 01/24/23
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Fate Therapeutics, Inc. (FATE) InvestorsBusiness Wire • 01/23/23
Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Fate Therapeutics, Inc. (FATE) InvestorsBusiness Wire • 01/23/23
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Fate Therapeutics, Inc. (FATE) InvestorsBusiness Wire • 01/23/23
SHAREHOLDER ALERT: Class Action Lawsuit Filed on Behalf of Fate Therapeutics, Inc. (FATE) Investors - Nationally Ranked Investors' Rights Firm Holzer & Holzer, LLC Encourages Investors With Significant Losses to Contact the FirmNewsfile Corp • 01/23/23
EQUITY ALERT: Rosen Law Firm Encourages Fate Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – FATEBusiness Wire • 01/23/23
Fate Therapeutics Shareholder Class Action Investigation: Submit Your Losses to Johnson FistelNewsfile Corp • 01/21/23
Down -52.57% in 4 Weeks, Here's Why Fate Therapeutics (FATE) Looks Ripe for a TurnaroundZacks Investment Research • 01/19/23
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of Fate Therapeutics, Inc. (FATE) on Behalf of InvestorsBusiness Wire • 01/19/23
ONGOING INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Fate Therapeutics, Inc. and Encourages Investors with Losses to Contact the FirmNewsfile Corp • 01/19/23
INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of Fate Therapeutics, Inc. (FATE) on Behalf of InvestorsBusiness Wire • 01/18/23
The Law Offices of Frank R. Cruz Continues Investigation of Fate Therapeutics, Inc. (FATE) on Behalf of InvestorsBusiness Wire • 01/17/23
Fate Therapeutics Investigated by Block & Leviton For Potential Securities Law Violations; Investors Who Have Lost Money Are Encouraged to Contact the FirmNewsfile Corp • 01/17/23
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages Fate Therapeutics, Inc. (FATE) Investors with Significant Losses to Contact Firm's Attorneys, Firm Investigating Possible Securities Law ViolationsNewsfile Corp • 01/13/23
ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Fate Therapeutics, Inc. and Encourages Investors with Losses to Contact the FirmNewsfile Corp • 01/12/23
FATE ALERT: Bragar Eagel & Squire, P.C. is Investigating Fate Therapeutics, Inc. on Behalf of Fate Stockholders and Encourages Investors to Contact the FirmBusiness Wire • 01/12/23
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Fate Therapeutics, Inc. (FATE) on Behalf of InvestorsBusiness Wire • 01/11/23
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Fate Therapeutics, Inc. (FATE) on Behalf of InvestorsBusiness Wire • 01/11/23
The Law Offices of Frank R. Cruz Announces Investigation of Fate Therapeutics, Inc. (FATE) on Behalf of InvestorsBusiness Wire • 01/11/23
ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Fate Therapeutics, Inc. and Encourages Investors with Losses to Contact the FirmNewsfile Corp • 01/11/23
INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Fate Therapeutics, Inc. and Encourages Investors with Losses to Contact the FirmNewsfile Corp • 01/10/23
